Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 17, Number 6—June 2011

Cefepime-Resistant Pseudomonas aeruginosa

Ehimare Akhabue, Marie Synnestvedt, Mark G. Weiner, Warren B. Bilker, and Ebbing LautenbachComments to Author 
Author affiliations: Author affiliation: University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania, USA

Main Article

Table 3

Multivariable model of association between infection with cefepime-resistant Pseudomonas aeruginosa and death, Philadelphia, PA, USA, 2001–2006*

Variable Adjusted OR (95% CI) p value
Cefepime-resistant organism 1.28 (0.86–1.90) 0.232
Patient in ICU at time of culture 2.33 (1.75–3.10) <0.001
APR-DRG 11.29 (6.53–19.50) <0.001
Patient transfer from outside hospital 1.38 (1.05–1.81) 0.021
Length of hospital stay before culture 0.99 (0.98–1.00) 0.231

*OR, odds ratio; CI, confidence interval; ICU, intensive care unit; APR-DRG, all-patient refined-diagnosis–related group.

Main Article

Page created: September 01, 2011
Page updated: September 01, 2011
Page reviewed: September 01, 2011
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.